Home > Pulmonology > NLC 2022 > No oral corticosteroids before a confirmed diagnosis of ILD

No oral corticosteroids before a confirmed diagnosis of ILD

NLC 2022
Data from a Finnish study assessing the pre-operative risk factors for transbronchial lung cryobiopsy (TBLC) complications in patients with interstitial lung disease (ILD) showed that it might not be wise to use oral corticosteroids in these patients before a confirmed diagnosis. Also, a severe cough should be investigated before TBLC is considered. Not much is known about the pre-operative risk factors associated with TBLC complications. Therefore, a study evaluating the pre-operative risk factors of clinically significant complications of TBLC in patients with ILD was initiated. The study also aimed to describe the Finnish TBLC procedure and report complication rates and diagnostic yield. A total of 100 patients with a median age of 66.1 years and of whom 60 were men were recruited between January 2015 and December 2019. The inclusion criteria consisted of a referral for a suspected ILD and a requirement of a histological investigation in the diag...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on